ANCR
NEUTRALAnimalcare expands into Australian pet health market with strategic investment
The veterinary group has acquired a 25% stake in an Australian pet health business to expand its presence in the Asia-Pacific region.
Animalcare Group
280.17GBX
-0.65%
Market Cap
193.29M
Volume
209
0% of avg
P/E Ratio
0.23
EPS (TTM)
12.19
Beta
0.42
Day Range
280.17p - 288.00p
52 Week Range
202.00p280.17p305.35p
280.17p
Upcoming Events
ANCR
NEUTRALAnimalcare Group Announces Major Shareholding Change
The healthcare company has received notification of a change in major shareholding, with Harwood Capital LLP now holding 9.929% of the voting rights.
ANCR
NEUTRALAnimalcare Group Publishes 2024 Annual Report
The veterinary sales and marketing company has published its latest annual report and announced the date for its 2025 AGM.
ANCR
NEUTRALAnimalcare Group Reports Strong Financial Performance and Strategic Progress in 2024
The veterinary pharmaceuticals company reported revenue growth across all product categories and improved profitability. However, challenges such as input inflation and a competitive landscape temper the outlook.
ANCR
NEUTRALAnimalcare Group Sees Major Shareholding Change
The healthcare company has seen a major shareholder increase their stake in the business.
ANCR
NEUTRALAnimalcare Group Announces Results and Presentations
The veterinary sales and marketing company announces the date of its annual results and upcoming investor presentations.
ANCR
GOODAnimalcare Group Reports Strong Revenue Growth and Strategic Expansion
Vet pharma firm expands globally
ANCR
GOODAnimalcare Completes Randlab Acquisition, Expanding International Footprint
Veterinary healthcare company Animalcare completes strategic acquisition, expanding its global reach.
ANCR
NEUTRALAnimalcare Appoints New Alternate Director
Veterinary pharmaceuticals company Animalcare appoints new Alternate Director
ANCR
NEUTRALAnimalcare Group Sees Shift in Major Shareholding
Healthcare company Animalcare Group sees change in major shareholding